ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising improvements across many healthcare and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, far more reliable alternative for therapeutic use, notably